MERRIMACK PHARMACEUTICALS INC 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Feb 10, 2016
Insider Transaction Report
Form 4
Mulroy Robert J.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2016-02-08+250,000→ 250,000 totalExercise: $5.42Exp: 2026-02-07→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]This option vests as to 1/12th of the total number of shares on 5/8/16 and an additional 1/12th of the total number of shares at the end of each successive three month period thereafter until 2/8/19.